56 related articles for article (PubMed ID: 2858052)
21. Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementias.
Grossman F; Okamoto A; Turkoz I; Gharabawi G
J Am Geriatr Soc; 2004 May; 52(5):852-3. PubMed ID: 15086685
[No Abstract] [Full Text] [Related]
22. Lack of clinical efficacy of chronic oral physostigmine in Alzheimer's disease.
Jotkowitz S
Ann Neurol; 1983 Dec; 14(6):690-1. PubMed ID: 6360031
[TBL] [Abstract][Full Text] [Related]
23. Effects of phosphatidylserine in Alzheimer's disease.
Crook T; Petrie W; Wells C; Massari DC
Psychopharmacol Bull; 1992; 28(1):61-6. PubMed ID: 1609044
[TBL] [Abstract][Full Text] [Related]
24. Is donepezil effective for treating Alzheimer's disease?
Steele LS; Glazier RH
Can Fam Physician; 1999 Apr; 45():917-9. PubMed ID: 10216789
[No Abstract] [Full Text] [Related]
25. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
Beal MF; Mazurek MF; Svendsen CN; Bird ED; Martin JB
Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
[TBL] [Abstract][Full Text] [Related]
26. [Naftidrofuryl in patients with multi-infarct dementia and Alzheimer's disease].
Grossmann W; Standl A; May U
Vasa Suppl; 1988; 24():48-55. PubMed ID: 3212603
[No Abstract] [Full Text] [Related]
27. Therapeutic frontiers in Alzheimer's disease.
Miller SW; Mahoney JM; Jann MW
Pharmacotherapy; 1992; 12(3):217-31. PubMed ID: 1608856
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.
Wilkinson D; Andersen HF
Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761
[TBL] [Abstract][Full Text] [Related]
29. Cognitive and behavioral sensitivity to scopolamine in Alzheimer patients and controls.
Sunderland T; Tariot PN; Mueller EA; Murphy DL; Weingartner H; Cohen RM
Psychopharmacol Bull; 1985; 21(3):676-9. PubMed ID: 3898182
[No Abstract] [Full Text] [Related]
30. Intravenous immunoglobulin for Alzheimer's disease.
Relkin N
Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):27-9. PubMed ID: 25546751
[No Abstract] [Full Text] [Related]
31. Choline therapy in Alzheimer's disease.
Smith CM; Swash M; Exton-Smith AN; Phillips MJ; Overstall PW; Piper ME; Bailey MR
Lancet; 1978 Aug; 2(8084):318. PubMed ID: 79110
[No Abstract] [Full Text] [Related]
32. Lecithin in the treatment of Alzheimer's disease.
Weintraub S; Mesulam MM; Auty R; Baratz R; Cholakos BN; Kapust L; Ransil B; Tellers JG; Albert MS; LoCastro S; Moss M
Arch Neurol; 1983 Aug; 40(8):527-8. PubMed ID: 6347143
[No Abstract] [Full Text] [Related]
33. Alzheimer's disease. Using direct drug infusion to the central nervous system.
Reeder TM; Hohmann M
AORN J; 1986 Aug; 44(2):222, 224-30, 232. PubMed ID: 3530130
[No Abstract] [Full Text] [Related]
34. Insulin. A memory hormone?
Harv Health Lett; 2000 Feb; 25(4):7. PubMed ID: 10637018
[No Abstract] [Full Text] [Related]
35. New treatments in Alzheimer's disease.
Pickrell WO; Robertson NP
J Neurol; 2018 Sep; 265(9):2162-2163. PubMed ID: 30132064
[No Abstract] [Full Text] [Related]
36. Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa.
Strittmatter M; Hamann GF; Strubel D; Cramer H; Schimrigk K
J Neural Transm (Vienna); 1996; 103(5):591-602. PubMed ID: 8811504
[TBL] [Abstract][Full Text] [Related]
37. Advances in the pharmacotherapy of Alzheimer's disease.
Soares JC; Gershon S
Eur Arch Psychiatry Clin Neurosci; 1994; 244(5):261-71. PubMed ID: 7893772
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin and Alzheimer's disease: a hypothesis.
Reubi JC; Palacios J
J Neurol; 1986 Nov; 233(6):370-2. PubMed ID: 2879894
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and pharmacological approaches in Alzheimer's disease.
Hermann C; Stern RG; Losonzcy MF; Jaff S; Davidson M
Drugs Aging; 1991 Mar; 1(2):144-62. PubMed ID: 1794010
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of an analogue of somatostatin (L363,586) in Alzheimer's disease.
Cutler NR; Haxby JV; Narang PK; May C; Burg C; Reines SA
N Engl J Med; 1985 Mar; 312(11):725. PubMed ID: 2858052
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
